RSK-dependent 14-3-3 interactions
Abstract
Full Text:
PDFReferences
Moore BW. Chemistry and Biology of Two Proteins, S-100 and 14-3-2, Specific to the Nervous System. In: Carl CP, John RS, eds. International Review of Neurobiology: Academic Press. 1972:215-25.
Aitken A. 14-3-3 proteins: A historic overview. Seminars in Cancer Biology. 2006;16:162-72.
Obsil T, Obsilova V. Structural basis of 14-3-3 protein functions. Seminars in Cell & Developmental Biology. 2011;22:663-72.
Wilker E, Yaffe MB. 14-3-3 Proteins—a focus on cancer and human disease. J Molec Cellul Cardio. 2004;37:633-42.
Dougherty MK, Morrison DK. Unlocking the code of 14-3-3. J Cell Sci. 2004;117:1875-84.
Anjum R, Blenis J. The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol. 2008;9:747-58.
Galan JA, Geraghty KM, Lavoie G, Kanshin E, Tcherkezian J, Calabrese V1, et al. Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3. Proc Natl Acad Sci USA. 2014;111(29):E2918-27.
Saha M, Carriere A, Cheerathodi M, Zhang X, Lavoie G, Rush J, et al. RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation. Biochem J. 2012;447(1):159-66.
Masters SC, Yang H, Datta SR, Greenberg ME, Fu H. 14-3-3 Inhibits Bad-Induced Cell Death through Interaction with Serine-136. Molecular Pharmacology. 2001;60:1325-31.
Stratford AL, Dunn SE. The promise and challenges of targeting RSK for the treatment of cancer. Expert Opinion on Therapeutic Targets. 2011;15:1-4.
Freeman AK, Morrison DK. 14-3-3 Proteins: Diverse Functions in Cell Proliferation and Cancer Progression. Seminars in cell and developmental biology. 2011;22:681-7.
Shen, Ying H. Significance of 14-3-3 Self-Dimerization for Phosphorylation-Dependent Target Binding.” Ed. Mark Ginsberg. Molecular Biology of the Cell. 2003:4721-33.
Rajalingam K, Schreck R, Rapp UR, Albert S. Ras oncogenes and their downstream targets, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2007;1773(8):1177-95.